Uncovering gene expression patterns, spatial transcriptomics bridges molecular analysis and tissue morphology, advancing research in various biological fields.

In untreated patients with cervical cancer in situ (meaning it developed there and ... Most cervical cancers are squamous carcinomas, but about 10 percent are clear cell adenocarcinomas - a cancer of ...

Neo-adjuvant nivolumab or nivolumab with ipilimumab in advanced cutaneous squamous cell carcinoma prior to surgery. ClinicalTrials.gov. Updated October 26, 2022.

The receptor for the complement component C5a may be a useful therapeutic target for cases of cutaneous squamous cell carcinoma (cSCC), according to a new report. 1 The study, published in the ...

Patients who have cutaneous squamous-cell carcinoma with high-risk features are at risk for recurrence after definitive local therapy. The benefit of systemic adjuvant therapy options has not been ...

Survival for head and neck squamous cell carcinoma treated with versus without neoadjuvant systemic therapy: A national propensity score–matched analysis.. If you have the appropriate software ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...

A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery.

Mohs surgery significantly improved recurrence, metastasis, and mortality rates in patients with primary high-stage cutaneous cell carcinoma in a retrospective cohort study of 216 patients treated ...

Finally, samples from laryngeal squamous cell cancer (LSCC) were conducted by spatial transcriptomics (ST) to further validate the results of CDRscore model. Results: T cells from HNC patients ...

Surgery was the most effective treatment for cutaneous squamous cell carcinoma in situ, however, variations among other treatment approaches exist.

Researchers assessed the rate of patients with basal cell carcinoma and squamous cell carcinoma who had residual histologic tumor at the time of Mohs micrographic surgery.